UPDATE: Turning Point Therapeutics Inc. (TPTX) Announces Proposed Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Turning Point Therapeutics Inc. (TPTX) Prices 5.42M Share Common Offering at $60/Sh
May 19, 2020 5:43 AM EDTTurning Point Therapeutics, Inc. (NASDAQ: TPTX) today announced the pricing of its previously announced underwritten public offering of 5,416,667 shares of its common stock at a price to the public of $60.00 per share. The gross proceeds to Turning Point from the offering, before deducting underwriting... More
Turning Point Therapeutics Inc. (TPTX) PT Raised to $75 at Roth Capital
May 14, 2020 7:10 AM EDTRoth Capital analyst Zegbeh Jallah raised the price target on Turning Point Therapeutics Inc. (NASDAQ: TPTX) to $75.00 (from $65.00) while maintaining a Buy rating.... More



